Estrella Immunopharma, Inc. ESLA 深 沪
等待开盘 02-03 09:30:00 美东时间
1.09
-0.030
-2.68%
华盛通- 最 高1.19
- 今 开1.11
- 成交量 4.80万股
- 最 低 1.0704
- 昨 收 1.12
- 总市值 3942.05万
- 52周最高 3.15
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 0.7301
- 委 比 98.33%
- 总股本 3616.56万
- 历史最高 33.00
- 量 比 0.60
- 振 幅 10.68%
- 历史最低 0.00
- 每 手 1
- 风险率 0.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8
D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and lowers the price target from $16 to $8.
01-28 20:04
Estrella Immunopharma Offers Up To 2,541,206 Shares For Resale By The Selling Stockholders
ESTRELLA IMMUNOPHARMA, INC.Up to 2,541,206 Shares of Common StockThis prospectus relates to the offer and resale from time to time by the selling stockholders named in this prospectus (the "Selling Stockholders") of
2025-12-23 00:00
Estrella Immunopharma Recommended By Independent Data Safety Monitoring Board To Advance STARLIGHT-1 Study To Phase II After Review Of Safety Data
Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune
2025-12-04 21:04
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target
D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.
2025-11-04 00:23
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Strata Skin Sciences (NASDAQ:SSKN) shares increased by 44.9% to $2.23 ...
2025-10-15 01:06
Estrella Immunopharma Regains Nasdaq Compliance
Estrella Immunopharma ( ($ESLA) ) has provided an announcement. Estrella Immuno...
2025-09-30 05:49
Estrella Immunopharma Appoints Jia Dengyao to Board
Estrella Immunopharma ( ($ESLA) ) has provided an announcement. On September 22...
2025-09-27 05:48
美股大行评级 | 潜在涨幅921.1%！Intensity Therapeutics获Brookline Capital升级至"买入"，目标价上调至3美元
今日重点评级关注：Brookline Capital：上调Intensity Therapeutics评级至"买入"，目标价3美元；Chardan Capital：维持Taysha Gene Therapies"买入"评级，目标价从9美元升至10美元
2025-08-13 09:10
